CIPOLLI, MARCO
 Distribuzione geografica
Continente #
NA - Nord America 2.155
EU - Europa 1.921
AS - Asia 1.503
SA - Sud America 222
Continente sconosciuto - Info sul continente non disponibili 69
AF - Africa 43
OC - Oceania 4
Totale 5.917
Nazione #
US - Stati Uniti d'America 2.100
RU - Federazione Russa 804
SG - Singapore 533
CN - Cina 469
GB - Regno Unito 374
IT - Italia 206
BR - Brasile 167
VN - Vietnam 165
HK - Hong Kong 111
SE - Svezia 99
DE - Germania 89
FR - Francia 88
IE - Irlanda 77
FI - Finlandia 72
KR - Corea 59
BD - Bangladesh 47
CA - Canada 31
IN - India 27
JP - Giappone 18
NL - Olanda 18
EC - Ecuador 17
ID - Indonesia 17
AR - Argentina 16
BE - Belgio 16
ES - Italia 16
MX - Messico 15
ZA - Sudafrica 15
PL - Polonia 14
UA - Ucraina 13
TR - Turchia 11
NG - Nigeria 9
AT - Austria 8
PK - Pakistan 7
SA - Arabia Saudita 7
UZ - Uzbekistan 7
IQ - Iraq 6
PY - Paraguay 6
BJ - Benin 5
CO - Colombia 5
AU - Australia 4
CH - Svizzera 4
LT - Lituania 4
MA - Marocco 4
BO - Bolivia 3
CL - Cile 3
CR - Costa Rica 3
CZ - Repubblica Ceca 3
TG - Togo 3
BG - Bulgaria 2
EG - Egitto 2
JM - Giamaica 2
JO - Giordania 2
KG - Kirghizistan 2
KZ - Kazakistan 2
MD - Moldavia 2
OM - Oman 2
PE - Perù 2
UY - Uruguay 2
AD - Andorra 1
AE - Emirati Arabi Uniti 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BY - Bielorussia 1
CG - Congo 1
CY - Cipro 1
DM - Dominica 1
DZ - Algeria 1
EU - Europa 1
GA - Gabon 1
GE - Georgia 1
GR - Grecia 1
HR - Croazia 1
HU - Ungheria 1
IL - Israele 1
IR - Iran 1
KH - Cambogia 1
LB - Libano 1
LV - Lettonia 1
MT - Malta 1
MY - Malesia 1
NI - Nicaragua 1
NO - Norvegia 1
NP - Nepal 1
PH - Filippine 1
RO - Romania 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
SV - El Salvador 1
VE - Venezuela 1
YT - Mayotte 1
Totale 5.849
Città #
Southend 303
Dallas 285
Singapore 277
Moscow 275
Ashburn 270
Chandler 248
San Jose 205
Beijing 110
Hong Kong 109
Woodbridge 91
Ann Arbor 87
Verona 85
Dublin 77
The Dalles 69
Jacksonville 58
New York 57
Council Bluffs 56
Ho Chi Minh City 50
Los Angeles 46
Houston 44
Helsinki 39
Hanoi 38
Nanjing 36
Munich 29
Lawrence 28
Princeton 28
Jinan 27
Buffalo 24
Shenyang 24
Seoul 23
Wilmington 22
Santa Clara 20
São Paulo 19
Tokyo 17
Milan 16
Brussels 14
Hebei 14
Amsterdam 13
Changsha 13
Montreal 12
Warsaw 12
Dong Ket 11
Jakarta 11
Johannesburg 11
London 11
Columbus 10
Denver 10
Redondo Beach 10
Taizhou 10
Turku 10
Abuja 9
Ankara 9
Boardman 9
Bologna 9
Chennai 9
Nanchang 9
Ningbo 9
Stockholm 9
Chicago 8
Frankfurt am Main 8
Haikou 8
Orem 8
Tianjin 8
Brooklyn 7
San Francisco 7
Sindelfingen 7
Tashkent 7
Zhengzhou 7
Falkenstein 6
Ferrara 6
Hangzhou 6
Jiaxing 6
Norwalk 6
Quito 6
Rome 6
Seattle 6
Vienna 6
Asunción 5
Atlanta 5
City of London 5
Cotonou 5
Falls Church 5
Guangzhou 5
Hải Dương 5
Lanzhou 5
Lappeenranta 5
Mexico City 5
Osasco 5
Redwood City 5
Rio de Janeiro 5
Taiyuan 5
Toronto 5
Washington 5
Auburn Hills 4
Baghdad 4
Boston 4
Guayaquil 4
Haiphong 4
Mumbai 4
Nuremberg 4
Totale 3.673
Nome #
International phase III trial of liprotamase efficacy and safety in pancreatic-insufficient cystic fibrosis patients. 284
A longitudinal study of glucose tolerance in cystic fibrosis: the central role of beta cell functional mass 205
Ataluren-driven Restoration of Shwachman-Bodian-Diamond Syndrome Protein Function in Shwachman-Diamond Syndrome Bone Marrow Cells 202
Further characterization of Shwachman-Diamond syndrome: psychological functioning and quality of life in adult and young patients. 194
Ataluren improves hematopoietic and pancreatic disorders in Shwachman-Diamond syndrome patients: a compassionate program case-series 186
Further Insights into the Hematological Disorders Observed in Shwachman-Diamond Syndrome: mTOR and STAT3 Hyper-Phosphorylation in CD4+ and CD8+ T Cells and Efficacy of Rapamycin Treatment 183
mTOR and STAT3 Pathway Hyper-Activation is Associated with evated Interleukin-6 Levels in Patients with Shwachman-Diamond Syndrome: Further Evidence of Lymphoid Lineage Impairment 181
Type of CFTR mutation determines risk of pancreatitis in patients with cystic fibrosis. 179
Evaluation of energy metabolism and calcium homeostasis in cells affected by Shwachman-Diamond syndrome 173
Draft consensus guidelines for diagnosis and treatment of Shwachman-Diamond syndrome. 171
291 Colon cancer screening program in adult CF patients: an Italian cross-sectional pilot study 168
Identification of novel mutations in patients with Shwachman-Diamond syndrome 168
Absence of acquired copy number neutral loss of heterozygosity (CN-LOH) of chromosome 7 in a series of 10 patients with Shwachman-Diamond syndrome 164
Real-Life Experience with CFTR Modulators Shows Correction of LAD-IV Phenotype in Cystic Fibrosis 160
Optical Measurements of Sweat for in Vivo Quantification of CFTR Function in Individual Sweat Glands 160
A Prospective Study of Hematologic Complications and Long-Term Survival of Italian Patients Affected by Shwachman-Diamond Syndrome 158
Ataluren improves myelopoiesis and neutrophil chemotaxis by restoring ribosome biogenesis and reducing p53 levels in Shwachman-Diamond syndrome cells 156
Forkhead box protein 3 (FOXP3) mutations lead to increased TH17 cell numbers and regulatory T-cell instability. 155
GENETIC ANALYSIS OF THE SBDS GENE AMONG NON-ITALIAN PATIENTS 151
A Prospective Haematological Survey Of Italian Patients Affected By Shwachman-Diamond Syndrome: Results Of A Ten Years Multicentric Study 151
Shwachman-Diamond syndrome 147
Impact of CFTR Modulators on Beta-Cell Function in Children and Young Adults with Cystic Fibrosis 141
Constitutive systemic inflammation in Shwachman-Diamond Syndrome 141
Peripheral blood immunophenotyping in a large cohort of patients with Shwachman-Diamond syndrome 140
Immunogenicity and Safety of the BNT162b2 COVID-19 Vaccine in Patients with Cystic Fibrosis with or without Lung Transplantation 135
Shwachman-Diamond syndrome with clonal interstitial deletion of the long arm of chromosome 20 in bone marrow: haematological features, prognosis and genomic instability 135
Celiac disease and obesity: need for nutritional follow-up after diagnosis. 133
Mutation Screening of Elongation Factor 2 in Shwachman-Diamond Syndrome Patients Lacking Mutations in the SBDS Gene 130
Normative growth charts for Shwachman-Diamond syndrome from Italian cohort of 0-8 years old 130
Novel Translational Read-Through–Inducing Drugs as a Therapeutic Option for Shwachman-Diamond Syndrome 130
SARS-CoV-2 viral entry and replication is impaired in Cystic Fibrosis airways due to ACE2 downregulation 129
Mesenchymal stem cells from Shwachman-Diamond syndrome patients display normal functions and do not contribute to hematological defects 127
Efficacy of Elexacaftor–Tezacaftor–Ivacaftor on chronic rhinosinusitis in cystic fibrosis 116
Whole exome sequencing discloses heterozygous variants in the DNAJC21 and EFL1 genes but not in SRP54 in 6 out of 16 patients with Shwachman-Diamond Syndrome carrying biallelic SBDS mutations 115
New insights into the Shwachman-Diamond Syndrome-related haematological disorder: hyper-activation of mTOR and STAT3 in leukocytes 113
Development of translational read-through-inducing drugs as novel therapeutic options for patients with Fanconi anemia 99
Mesenchymal stromal cells from Shwachman-Diamond syndrome patients fail to recreate a bone marrow niche in vivo and exhibit impaired angiogenesis 93
Structural variation in SBDS gene, with loss of exon 3, in two Shwachman-Diamond patients 91
The Gluten Free Diet's Impact on Growth in Children with Celiac Disease in Two Different Countries 86
Modulation of immune responses by elexacaftor/tezacaftor/ivacaftor therapy in cystic fibrosis: data from a compassionate use program 32
Beyond readthrough: ataluren restores mitochondrial function and reduces oxidative stress in FANCA-mutated cells via mTOR–DRP1 modulation 5
Totale 5.917
Categoria #
all - tutte 19.553
article - articoli 18.082
book - libri 0
conference - conferenze 1.471
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 39.106


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022199 0 75 1 11 7 3 4 15 7 6 17 53
2022/2023587 32 81 42 113 48 134 4 32 68 8 15 10
2023/2024307 9 23 21 37 33 47 11 32 7 28 42 17
2024/2025852 34 30 36 164 36 33 44 32 150 38 71 184
2025/20262.912 146 155 314 510 685 176 252 153 209 167 64 81
2026/202757 38 19 0 0 0 0 0 0 0 0 0 0
Totale 5.917